Article Versions Notes

Hu F, Hu C, He Y, Guo L, Sun Y, Han C, Zhang X, Ren J, Han J, Wang J, et al. IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma. Cells. 2025; 14(15):1222. https://doi.org/10.3390/cells14151222

Hu, Feiming, Chenchen Hu, Yuanli He, Lin Guo, Yuanjie Sun, Chenying Han, Xiyang Zhang, Junyi Ren, Jinduo Han, Jing Wang, and et al. 2025. "IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma" Cells 14, no. 15: 1222. https://doi.org/10.3390/cells14151222

Hu, F., Hu, C., He, Y., Guo, L., Sun, Y., Han, C., Zhang, X., Ren, J., Han, J., Wang, J., Zhang, J., Sun, Y., Cai, S., Jiang, D., Yang, K., & Yang, S. (2025). IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma. Cells, 14(15), 1222. https://doi.org/10.3390/cells14151222